The activity of the somatotrophic function in Functional Hypothalamic Amenorrhea (FHA) related to undernourishmant;Interacciones de la respuesta del eje somatotrófico en la amenorrea hipotalámica funcional relacionada con la desnutrición

Revista Argentina de Endocrinologia y Metabolismo

Volumn 48, Issue 1, 2011, Pages 38-50

  Fiszlejder, León ^a  

^a HOSPITAL DURAND   (Argentina)

Author keywords

Amenorrhea; GH; GH resistance; Ghrelin; IGF I

Indexed keywords

ADIPOCYTOKINE; FATTY ACID; GHRELIN; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; INSULIN; LEPTIN; SOMATOMEDIN B; SOMATOMEDIN C;

AMENORRHEA; CARDIOVASCULAR RISK; DIET RESTRICTION; DOWN REGULATION; FUNCTIONAL HYPOTHALAMIC AMENORRHEA; HOMEOSTASIS; HORMONE RELEASE; MALNUTRITION; METABOLIC ACIDOSIS; METABOLISM; PROTEIN DEGRADATION; REVIEW;

EID: 79959712643     PISSN: 03264610     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. Fiszlejder L. Etiopatogenia de la amenorrea hipotalámica funcional. Interacción de las respuestas hormonales del sistema nervioso central y neuropéptidos periféricos. Rev Argent Endocrinol Metab 45: 75-88; 2008.
2. Fiszlejder L. Desnutrición y amenorrea hipotalámica funcional. Neuropéptidos periféricos (Leptina, Adiponectina, Ghrelina) y su relación con la homeostasis metabólica. Rev Argent Endocrinol Metab 46: 11-21; 2009.
3. Golden N, Kreitzer P, Jacobson M y col. Disturbances in growth hormone secretion and actions in adolescents with anorexia nervosa. J Pediatr 125: 655-660; 1994.
4. Nussbaunn M, Bleten S, Chsalow F y col. Blunted growth hormone responses to clonidine in adolescents girls with early anorexia nervosa . Evident for an early hypothalamic defect. J Adolesc Heart Care 11: 145-148; 1990.
5. Misra M, Miller K, Almazan C y col. Hormonal and body composition predictors of soluble leptin receptors, leptin and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. J Clin Endocrinol Metab 89: 3486-3495; 2004.
6. Stoving R., Veldhuis J, Flyvbjerg A y col. Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-Insulin-Like Growth Factor I axis. J Clin Endocrinol Metab 84: 2056-2063; 1999.
7. Argente J, Caballo N, Barrios V y col. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa; effect of short and long term weight recuperation. J Clin Endocrinol Metab 82: 2084-2092; 1997.
8. Misra M, Miller K, Bjomson J y col. Alterations in growth hormone secretory dinamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 88: 5615-5623; 2003.
9. Yen S S C. Chronic anovulation due to CNS-hypothamic-pituitary dysfunction. En: Reproductive Endocrinology. Yen S.S.C. y Jaffe R.B. Saunders W.B., pp 631-688; 1991.
10. Tamai H, Barini A, Caroln G y col. Responses of growth hormone and cortisol to intravenous glucose loading test in patients with anorexia nervosa. Metabolism 40: 31-34; 1991.
11. Misra M, Miller K, Herzog D y col. Growth hormone and Ghrelin response to an oral glucose load in adolescent girls with anorexia nervosa and controls. J Clin Endocronol Metab 89: 1605-1612; 2004.
12. Nakai Y, Hosada H, Nin K y col. Plasma levels of active form of Ghrelin during oral glucose tolerance test in patients with anorexia nervosa. Eur J Endocrinol 149: R1-R3; 2003.
13. Nedvidkova J, Krykokaova I, Bartak V y col. Loss of meal-induced decrease plasma ghrelin levels in patients with anorexia nervosa. J Clin Endocrinol Metab 88:1678-1682; 2003
14. Stoving R, Andersen M, Flybert A y col. Indirect evidence decreaced hypothalamic somatostatinergic tone in anorexia nervosa. Clin Endocrinol 56: 391-396; 2002.
15. Kave W, Rubinow D, Gwirtsman HE y col. CSF Somatostatin in anorexia nervosa and bulimia, relationships to the hypothalamic-pituitary-adrenal- cortisol axis. Pschoneuroendocrinology 13: 265-272; 1988.
16. Muller E, Locatelli V, Cocchi D. Neuroendocrine control of growth hormone secretion. Physiol Rev 9: 511-607; 1999.
17. Locatelli V, Torsello A, Redaelli M y col. Chol-inergic agonist and antagonist drugs modulate the growth reponse to growth hormone-releasing hormone in the rat evidence for mediation by somatostatin. J Endcrinol 111: 271-78, 1986. (Pubitemid 16010284)
18. Penalva A, Muruais C, Casanueva F y col. Effect of enhancement of endogenous cholinergic tone with pyridostigmine on the fose-response relationships of growth hormone (GH)-releasing hormone induced GH secretion in normal subjects. J Clin Endocrinol Metab 70: 324-327; 1999.
19. De Vris W, Abdesslan S, Schers T y col. Complete inhibition of hypothalamic somatostatin activity is only partially responsible for the growth hormone response to strenuous exercise. Metabolism 51: 1093-1096; 2002.
20. Massara F, Ghigo E, Demmislis K y col. Chol-inergic involvement in the growth hormone release studies in normal and acromegalic subjects. Neuroendocrinology 43: 670-67; 1986.
21. Richardson S, Hollander C, Deletto R y col. Acetylcholine inhibits the release of somatostatin from rat hypothalamus "in vitro". Endocrinology 107: 122-129; 1980.
22. Rolla M, Androni A, Belliti D y col. Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa, and atypical eating disorders. Biol Psych 27: 215-222; 1990.
23. Muller E, Rolla M, Ghigo E y col. Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Drugs 50: 805-837; 1995.
24. Giustina A, Veldhuis J. Patophysiology of the neuroendocrine of GH secretion in experimental animals and the human. Endocr Rev 19: 717-797; 1988.
25. Miel J, Corder R, Pralog F y col. Effects of dexamethasone on growth hormone releasing-hormone, arginine and dopaminergic stimulate GH secretion and total plasma insulin-like growth factor I concentrations in normal volunteers. J Clin Endocrinol Metab 72: 675-681; 1999.
26. Considine R, Weight regulation, leptine, growth hormone and growth secretion. Horm Res 48(supp5): 116-121; 1997.
27. Quintela M, Senaris R, Casanueva F y col. Leptin inhibits "in vitro" hypothalamic somatostatin secretion and somatostatin mRNA levels. Endocrinology 138: 5641-5644; 1997.
28. Scacchi M, Pinelli A, Cauno A y col. Spontaneous nocturnal growth secretion in anorexia nervosa. J Clin Endocrinol Metab 82: 3225-3229; 1997.
29. Laughlin G, Dominguez C, Yen S. Nutrional and endocrine metabolic aberrations in women with hypothalamic amenorrhea. J Clin Endocrinol Metab 83: 25-32; 1998.
30. Mercer J, Hoggard N, Williams L y col. Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleous of mouse hypothalamus. J Neuroendocrinol 8: 733-735; 1996.
31. Stephens T, Basinski M, Bristow P y col. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377: 530-532; 1995.
32. Wang Q, Bing C, Barazanji K y col. Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy-homeostasis in the rat. Diabetes 46: 335-41; 1997
33. Pelleymounter M, Cullen M, Baker M y col. Effects of the obese gene product on body weight regulation in ob/ob mice. Sience 269: 540-543; 1995.
34. Kalra S, Dube M, Pu S y col. Interacting appetite regulating pathways in the hypothalamic regulation of body weight. Endocrin Rev 20: 68-100; 1999.
35. Antoni F. Hypothalamic control of adrenocortropin secretion advances since the discovery of 41 residue corticotropin releasing factor. Endocr Rev 7: 351-378; 1986.
36. Perrin M, Donaldson C, Chen R y col. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 133: 3058-3061; 1993.
37. Potter S, Sutton S, Chen R y col. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Nat Acad Sci USA 91; 8777-8781; 1994.
38. Monnikes H, Heymann-Monnikes I, Tache Y. CRH in the paraventricular nucleous dose related behavioral profile in rats. Brain Res 574: 70-76; 1992.
39. Dunn A, Beridge C. Physiological and behavioral responses to CRH administration: is CRH a mediat-or of anxiety or stress responses?. Brain Res Rev 15: 71-100; 1990.
40. Britton D, Koob G, Vale W. Intraventricular corticotropin releasing factor enhances behavioral effects novelty. Life Sci 31: 363-367; 1982.
41. Shibasaki T, Yamauchi N, Kato Y y col. Involvement of corticotropin releasing factor in restraint stress induced anorexia and reversion of the anorexia by somatostatin in the rat. Life Scien 43: 1003-1110; 1988.
42. Wren A, Small C, Murphy H y col. The novel hypothalamic peptide ghrelin stimulates food intake and growth secretion. Endocrinology 141: 4225-4228; 2000.
43. Wren A, Seal L, Cohen M y col. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86: 5992-5999; 2001.
44. Lu S, Guan J, Wang Q y col. Inmmuno-cytochemical observation of ghrelin containing neurons in the rat arcuate nucleous. Neurosci Lett 321: 157-160; 2002.
45. Korbonitz M, Bustin S, Kojima M y col.The expresión of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumours. J Clin Endcrinol Metab 86: 881-887; 2001.
46. Tannenbaun G, Zang W, Lapointe M y col. Growth hormone-releasing-hormone neurons in the arcuate nucleous express both ssI and sst2 somatostatin receptor genes. Endocrinology 139: 1450-1443; 1998.
47. Clark R, Carlsson L, Trojnar J y col. The effects of a growth hormone-releasing peptide and growth hormone-releasing factor in conscious and anaesthethized rats. J Neuroendocrinol 1: 249-255; 1989.
48. Guillaune V, Magnan E, Cataldi M y col. Growth hormone (GH) releasing hormone secretion is stimulated by a new GH releasing hexapeptide in sheep. Endocrinology 135: 1073-1076; 1994.
49. Wren A, Small C, Fribbenns C y col. The hypothalamic mechanism of the hypophysiotropic action of Ghrelin. Neuroendocrinology 76: 316-324; 2002.
50. Mozida M, Trinsali G, Forling M y col. Ghrelin is released from rat hypothalamic explants and stimulated corticotropin releasing hormone and arginine-vasopresin. Horm Metab Res 35: 455-459; 2003.
51. Misra M, Miller K, Luo K y col. Secretory dinamics of ghrelin in adolescente girls with anorexia nervosa and healty adolescents. Am J Phsiol Endocrinol Metab 289: E47-E56; 2005.
52. Leal-Cerro A, Torres E, Soto A y col. Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggeratet corticotropin and cortisol responses. Neuroendocrinology 76: 390-396; 2002.
53. Miljic S, Pekic M, Djutovic M y col. Ghrelin has a partial or no effect on Appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa. J Clin Endocrinol Metab 91: 1491-1495; 2006.
54. Debra L, Clifford W, Quallis R y col. Increased pulsatilty, proceses irregularity, and nocturnal trough concentrations of growth hormone in amenorrheic compared to eumenorrheic athletes. J Clin Endocrinol Metab 86: 1013-1019; 2001.
55. Debra R, Counts H, Gwirtsman L y col. The effect of anorexia nervosa and refeeding on growth hormone-binding proteín, the IGFs and the IGF binding proteín. J Clin Encocrinol Metab 75: 762-767; 1992.
56. Gianotti L, Pincelli A, Scacchi M y col. Effects of recombinant human IGF-I administration on spontaneous and GHRH stimulated GH secretion in anorexia nervosa. J Clin Endocr Metab 85: 2805-2809; 2000.
57. Postel-Vinay M, Saab C, Gourmelem M. Nutrit-ional status and growth hormone-binding protein. Horm Res 44: 177-181; 1995.
58. Zamboni G, Dufilton D, Antoniazzi F y col. Growth hormone-binding protein in proteins-energy malnutrition before and after nutritional rehabilitation. Pediatr Res 39: 410-414; 1996.
59. Stoving R, Flybjerg A, Frystyk J y col. Low serum levels of free and total IGF-I in patients with anorexia nervosa are not associated with increased IGF Binding protein-3 proteolysis. J Clin Endocrinol Metab 84; 1346-1350; 1999.
60. Tamai H, Komaki G, Matsubayashi S y col. Effects of cholinergic- muscarinic receptor blockade on human growth hormone (GH) releasing hormone (1-44) induced GH secretion in anorexia nervosa. J Clin Endocrinol Metab 70: 738-741; 1990.
61. Rolla M, Andreoni A, Belletti D y col. Blockade of cholinergic muscarinic receptor by pirenzepine and GHRH induced secretion in the acute and recovery phase of anorexia nervosa and typical eating disorders. Biol Pschiatry 29: 1079-1091; 1991.
62. Ghigo E, Arvat E, Gianotti L y col. Arginine but not pyridostigmine, a cholinesterase inhibitor enhances the GHRH induced GH rice in patients with anorexia nervosa. Biol Pychiatry 36: 689-695; 1994.
63. Gianotti L, Arvat E, Valleto M y col. Effects of beta-adrenergic agonists and antagonists on the growth hormone response to GHRH in anorexia nervosa. Biol Psychiatry 43: 181-187; 1998.
64. Suikkari A, Koivisto V, Rutamen E y col. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrin Metab 66: 266-272; 1988.
65. Ooi G, Orlowski C, Brown D y col. Different tissue distribution and hormonal regulation of mRNA encoding rat insulin-like growth factot binding proteins rIGFBP-1 and IGF-2. Mol Endocrinol 4; 321-328; 1990.
66. Smith W, Underwood L, Clemons D. Effect of caloric or protein restrition on Insulin-like Growth Factor-I (IGF-I) and IGF-I Binding Protein in child-ren and adults. J Clin Endocrinol Metab 80: 443-449; 1995.
67. Pucilowka J, Davenpot M, Kabir L y col. The effects of dietary protein supplementation on insulin like growth factors (IGF"s) and IGF binding protein in chidren with shigellosis. J Clin Endocrinol Metab 77: 1516-1521; 1993.
68. Clemons D, Busby W, Synder D. Variables cont-rolling the secretion of insulin-like growth factor binding protein-2 in normal human subjects J Clin Endocrinol Metab73: 727-733; 1991.
69. Donovan S, Atlano L, Hintz R y col. Differential regulation of the insulin-like growth factors (IGF-I) and IGF binding proteins during nutrition in the neonatal rat. Endocrinology 129: 149-157; 1991.
70. Straus D, Takemoto C. Effect of dietary protein deprivation, insulin-like factor, IGF-I and II, IGF binding protein-2 and serum albumin gene expression in the rat. Endocrinology 127; 1849-1860; 1990.
71. Smith W, Nam T, Underwood L y col. Use of insulin-like growth factor binding protein-2 (IGFBP-2), IGFBP-3•and IGF-I for assessing growth hormone status in short children. J Clin Endocrinol Metab 77: 1294-1299; 1993.
72. Clemmons D, Klibanski A, Underwood L. Reduction of plasma immunoreactive somatomedin-C during fasting in humans. J Clin Endocrinol Metab 53: 1247-50; 1981.
73. Blum W, Jenne E, Reppin F y col. Insulin-like factor I (IGF-I) binding protein complex is a better mitogen than free IGF-I. Endocrinology 125: 766-772; 1989.
74. Katz L, Rosenfeld R, Cohen P. Clinical significance of Insulin-Like Growth Factor Binding Proteins. The Endocrinologist 5: 36-43; 1995.
75. Bar R, Clemmons D, Boes M y col. Transcapillary permeability and subendothelial distribution of endothelial and amniotic fluid IGF-binding proteins in the rat heart. Endocrinology 127: 1078-1086; 1990.
76. Mohn K, Melby A, Tewari D y col. The gene encoding rat insulin-like-growth factor binding protein 1 is rapidily and highly induced in regenerating liver. Mol Cell Biol 11: 1393-1401; 1991.
77. Orlowski C, Ooi G, Brown D y col. Insulin rapidly Inhibits insulin-like growth factor binding protein 1 expression in rat hepatoma cells. Mol Endocrinol 51: 1180-1187; 1990.
78. Snyder D, Clemmons D. Insulin dependent regulation of IGFBP-1. J Clin Endocrinol Metab 71: 1632-1636; 1990.
79. Busby W, Snyder D, Clemmons D. Radioimmunoassay of a 26000 dalton plasma insulin like growth factor binding protein: control by nutritional variables. J Clin Endocrinol Metab 67: 1225-1230; 1980.
80. Fiszlejder L. Ghrelina en la amenorrea hipotalámica funcional relacionada con la desnutrición. Rev Argent Endocrinol Metab 47: 27-35, 2010.
81. Tchop M, Smiley D, Heiman D. Ghrelin induced adiposity in rodents. Nature 409: 194-198; 2000.
82. Kamegai J, Tamura H, Shimizu T y col. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and agouti-related protein mRNA levels and body weight in rats. Diabetes 50: 2438-2443, 2001.
83. Herwson A, Dicson S. Systemic administration of ghrelin induces Fos and Egr-proteins in the hypothalalamic arcuate nucleous of fasted and fed rats. J Neuroendocrinol 1049-1459; 2000.
84. Tannenbaun G, Epelbaun J, Bowers C. Interrelationship between the novel peptide Ghrelin and Somatostatin/Growth Hormone-Releasing Hormone in regulation of pulsatile Growth Hormone secretion. Endocrinology 144: 967; 74.2003.
85. Seoane L, Lopez M, Tovar S y col. Agouit-related peptide, neuropeptide Y and somatostatin producing are targets for ghrelin actions in the rat hypothalamus. Endocrinology 144: 544-551; 2003.
86. Tolle V, Bassant M, Zizzari P y col. Ultradian rhymicity of ghrelin secretion in relation with feeding behavior and sleep patterns in rats. Endocrinology 143: 1353-1361; 2002.
87. Barkan A, Dimaraki E, Jessup S y col. Ghrelin secretion in humans is sexually dimorphic suppessed by somatostatin and not affected by the ambient growth hormone levels. J Clin Endocrinol Metab 2180-2184; 2003.
88. Muccioli G, Tshop M, Papotti M y col. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 440: 235-254; 2002.
89. Date Y, Nakazato M, Hashiguchi S y col. Ghrelin is present in pancreatic alpha cells of human and rats and stimulates insulin secretion. Diabetes 51: 124-129; 2002.
90. Cummings D, Pumell J, Frayo R y col. A preprandial rise in plasma ghrelin levels suggests a rol in meal initiation in humans. Diabetes 50: 1714-1719; 2001.
91. Broglio F, Arvat E, Benso A y col. Ghrelin, a natural GH secretagogue produced by the stomach induced hypergycemia and reduced insulin secretion in humans. J Clin Endocrinol Metab 86: 5083-5086; 2001.
92. Saad M, Bernaba B, Hwu C y col. Insulin regulates plasma ghrelin concentration J Clin Endocrinol Metab 87: 3997-4000; 2002.
93. Broglio F, Benso A, Gottero C y col. Effecrs of glucose free fatty acids or arginine load on the GH-releasin activity of ghrelin in humans. Clin Endocrinol 57: 265-271; 2002.
94. Broglio F, Prodant F, Gottero C y col. Ghrelin does not mediate the somatotrophe and corticotrophe responses to the stimulatory effect of glucagon or insulin induced hypoglycaemia in humans. Clin Endocrinol 60: 699-704; 2004.
95. ShiiyaT, Nakazato M, Mizuta M y col. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87: 240-244; 2002.
96. LaPaglia N, Steiner J, Kirstein L y col. Leptin alters the response of the growth hormone releasing factor growth hormone insulin-like growth-I axis to fasting. J Endocrinol 159: 79-83; 1998.
97. van der Lely A, Tschöp M, Heiman M y col. Biological, physiological, pathophysiological and pharmacological aspects of ghrelin. Endocr Rev 25: 426-457; 2004.
98. Garcia M, Lopez M, Casanueva F y col. Role of ghrelin in reproduction. Reproduction 133: 531-540; 2004.
99. Mc Nay E. Insulin and ghrelin: peripheral hormones modulating memory and hippocampal function. Curr Opin Pharmacol 7; 628-632; 2007.
100. Avran A, Jaffe G, Symons K y col. Endogenous-circulating Ghrelin does not mediate growth hormone rhythmicity or response to fasting. J Clin Endocrinol Metab 90: 2982-2987; 2005.
101. Jaffe G, Ho P, Demott-Friberg R y col. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. J Clin Endocrinol Metab 77: 1641-1647; 1993.
102. Bowers C, Rynolds C, Durhan D y col. Growth Hormone (GH) releasing peptide simulate release in normal men and acts synertically with GH releasing hormone. J Clin Endocrinol Metab 70: 975-982; 1990.
103. Laughlin G, Dominguez C, Yen S. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 83: 25-32 1998. (Pubitemid 28498306)
104. Veldhuis J, Meltzger D, Martha Jr P y col. Estrogen and testoterone but not a non aromatizable androgen direct network integration of the hypothalamo-somatotrope-IGF-I axis in the human: evidence from pubertal pathophysiology and sex steroid hormone replacement. J Clin Endocrinol Metab 82: 3414-3420, 1997. (Pubitemid 27419097)
105. Dosostalová I, Kaválollova P, Halzikova D y col. Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa. J Clin Endocrinol Metab 93: 3627-3632, 2008.
106. Fazeli P, Misra M, Goldstein M y col. Fibroblast Growth Factor-21 may mediate growth hormone resistance in anorexia nervosa. J Clin Endocrinol Metab 95: 369-374; 2010.
107. Badman M, Pissios P, Kennedy A y col. Hepatic fibroblast growth factor 21 is regulated by PPARa and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 5: 426-437; 2007.
108. Inagaki T, Dutchak P, Zhao G, Ding X y col. Endocrine regulation of the fasting response by PPARa mediated induction of fibroblast growth factor 21. Cell Metab 5: 415-425; 2007.
109. Inagaki T, Lin V, Goetz R y col. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab 8: 77-83; 2008.